Aspirin Use Does Not Reduce Risk of Colorectal Cancer Recurrence

Aspirin Use Does Not Reduce Risk of Colorectal Cancer Recurrence

There was no evidence that aspirin use beginning at the onset of chemotherapy affected the risk of recurrence among patients with stage II or III colorectal cancer.

Regorafenib Improves Overall Survival in Liver Cancer

Regorafenib Improves Overall Survival in Liver Cancer

Second-line systemic therapy with regorafenib improves overall survival among patients with hepatocellular carcinoma (HCC).

GEMOX Does Not Improve Relapse-free Survival in Biliary Tract Cancer

GEMOX Does Not Improve Relapse-free Survival in Biliary Tract Cancer

GEMOX post-surgery adjuvant therapy does not improve relapse-free survival (RFS) among patients with biliary tract cancer.

Advanced Pancreatic Cancer: 3 New Agents Improved Outcomes Between 1978-2015

Advanced Pancreatic Cancer: 3 New Agents Improved Outcomes Between 1978-2015

Phase 2 trials of investigational agents for pancreatic cancer treatment do not usually progress to phase 3.

Bursectomy Not Recommended as Standard Treatment for cT3/T4 Gastric Cancer

Bursectomy Not Recommended as Standard Treatment for cT3/T4 Gastric Cancer

Bursectomy can be safely performed without increasing the risk of morbidity or mortality among patients with cT3 or cT4 gastric cancer.

Ramucirumab Efficacious Regardless of Age in Gastric Cancer

Ramucirumab Efficacious Regardless of Age in Gastric Cancer

For patients with advanced gastric cancer, second-line treatment with ramucirumab is safe and efficacious regardless of age.

Nivolumab Efficacious as Salvage Therapy for Advanced Gastric Cancer

Nivolumab Efficacious as Salvage Therapy for Advanced Gastric Cancer

Salvage therapy with nivolumab was efficacious among patients with advanced or recurrent gastric or gastroesophageal junction (GEJ) cancer.

Adding Everolimus to Paclitaxel Not Effective for Advanced Gastric Cancer

Adding Everolimus to Paclitaxel Not Effective for Advanced Gastric Cancer

The addition of everolimus to paclitaxel did not significantly improve overall response rate, progression-free survival, or overall survival.

PET Scans Inform, Improve Treatment in Esophageal Cancer

PET Scans Inform, Improve Treatment in Esophageal Cancer

Altering chemotherapy during neoadjuvant chemoradiotherapy based on response to induction chemotherapy by PET imaging can improve pathologic complete response.

Physical Activity Associated With Improved PFS, OS in Advanced CRC

Physical Activity Associated With Improved PFS, OS in Advanced CRC

Among patients with advanced colorectal cancer, greater total physical activity improved progression-free and overall survival.

FOLFIRI and XELIRI Are Safe, Well-tolerated in Metastatic Colorectal Cancer

FOLFIRI and XELIRI Are Safe, Well-tolerated in Metastatic Colorectal Cancer

Despite differences in the safety profiles and rates of adverse events, both FOLFIRI and XELIRI were safe and well-tolerated as second-line therapy.

Watch-and-Wait Safe for Patients With Rectal Cancer

Watch-and-Wait Safe for Patients With Rectal Cancer

Omitting surgery and using a watch-and-wait approach does not compromise outcomes for selected patients with advanced rectal cancer.

Surgical Palliation for Gastric Outlet Obstruction

Surgical Palliation for Gastric Outlet Obstruction

Among patients with malignant gastric outlet obstruction caused by gastric cancer, surgical palliation was effective for maintaining patient quality of life.

Nintedanib Improves PFS in mCRC Regardless of Prior Regorafenib Treatment

Nintedanib Improves PFS in mCRC Regardless of Prior Regorafenib Treatment

Treatment with nintedanib significantly improved progression-free survival among heavily pretreated patients with metastatic colorectal cancer (mCRC).

Tumor-Specific Differences, Genomic Alterations of Biliary Tract Cancers Identified

Tumor-Specific Differences, Genomic Alterations of Biliary Tract Cancers Identified

Gastrointestinal cancers have a diverse landscape of clinically relevant genomic alterations (CRGA) that could lead to targeted drug therapy.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs